Zdrowie i gospodarka · 02/02/2000

FDA Reclassifies Penile Rigidity Implant from Class III to Class II for Erectile Dysfunction Treatment

The US Food and Drug Administration (FDA) is reclassifying the penile rigidity implant, intended to treat erectile dysfunction in men, from a Class III device to a Class II device, following new information and amendments to the Federal Food, Drug, and Cosmetic Act.